Literature DB >> 26867671

Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation.

M Kato1,2,3, T Yamashita4, R Suzuki5, K Matsumoto1, H Nishimori6, S Takahashi7, K Iwato8, C Nakaseko9, T Kondo10, K Imada11, F Kimura12, T Ichinohe13, Y Hashii14, K Kato15, Y Atsuta16,17, S Taniguchi18, T Fukuda4.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26867671     DOI： 10.1038/leu.2016.23

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

Review 1.  B-cell lymphoma developing in the donor 9 years after donor-origin acute myeloid leukemia post bone marrow transplantation.

Authors:  B Bielorai; H J Deeg; M Weintraub; Y Neumann; E Rosner; N Amariglio; G Rechavi; A Toren
Journal:  Bone Marrow Transplant       Date:  2003-05       Impact factor: 5.483

2.  Successful use of second cord blood transplantation to achieve long-term remission in cord blood donor cell-derived AML harboring a FLT3-ITD and an NPM1 mutation.

Authors:  K Chonabayashi; T Kondo; K Yamamoto; Y Tanaka; Y Nagai; M Hishizawa; A Takaori-Kondo
Journal:  Bone Marrow Transplant       Date:  2012-01-09       Impact factor: 5.483

3.  Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT).

Authors:  Bernd Hertenstein; Lothar Hambach; Andrea Bacigalupo; Norbert Schmitz; Shaun McCann; Shimon Slavin; Alois Gratwohl; Augustin Ferrant; Ahmet Elmaagacli; Rainer Schwertfeger; Anna Locasciulli; Axel Zander; Martin Bornhäuser; Dietger Niederwieser; Tapani Ruutu
Journal:  Haematologica       Date:  2005-07       Impact factor: 9.941

4.  Leukaemic transformation of engrafted human marrow cells in vivo.

Authors:  P J Fialkow; E D Thomas; J I Bryant; P E Neiman
Journal:  Lancet       Date:  1971-02-06       Impact factor: 79.321

5.  Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project.

Authors:  Tomohiro Matsuda; Tomomi Marugame; Ken-ichi Kamo; Kota Katanoda; Wakiko Ajiki; Tomotaka Sobue
Journal:  Jpn J Clin Oncol       Date:  2010-09-06       Impact factor: 3.019

6.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.

Authors:  Giulio Genovese; Anna K Kähler; Robert E Handsaker; Johan Lindberg; Samuel A Rose; Samuel F Bakhoum; Kimberly Chambert; Eran Mick; Benjamin M Neale; Menachem Fromer; Shaun M Purcell; Oscar Svantesson; Mikael Landén; Martin Höglund; Sören Lehmann; Stacey B Gabriel; Jennifer L Moran; Eric S Lander; Patrick F Sullivan; Pamela Sklar; Henrik Grönberg; Christina M Hultman; Steven A McCarroll
Journal:  N Engl J Med       Date:  2014-11-26       Impact factor: 91.245

7.  Identification of cytomegalovirus (CMV)pp65 antigen-specific human monoclonal antibodies using single B cell-based antibody gene cloning from melanoma patients.

Authors:  Akira Iizuka; Masaru Komiyama; Sachiko Tai; Chie Oshita; Ayumi Kurusu; Akiko Kume; Kazumichi Ozawa; Yoji Nakamura; Tadashi Ashizawa; Akifumi Yamamoto; Naoya Yamazaki; Shusuke Yoshikawa; Yoshio Kiyohara; Ken Yamaguchi; Yasuto Akiyama
Journal:  Immunol Lett       Date:  2010-10-12       Impact factor: 3.685

8.  PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.

Authors:  Stephen M Ansell; Alexander M Lesokhin; Ivan Borrello; Ahmad Halwani; Emma C Scott; Martin Gutierrez; Stephen J Schuster; Michael M Millenson; Deepika Cattry; Gordon J Freeman; Scott J Rodig; Bjoern Chapuy; Azra H Ligon; Lili Zhu; Joseph F Grosso; Su Young Kim; John M Timmerman; Margaret A Shipp; Philippe Armand
Journal:  N Engl J Med       Date:  2014-12-06       Impact factor: 91.245

9.  Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System.

Authors:  Yoshiko Atsuta; Ritsuro Suzuki; Ayami Yoshimi; Hisashi Gondo; Junji Tanaka; Akira Hiraoka; Koji Kato; Ken Tabuchi; Masahiro Tsuchida; Yasuo Morishima; Makoto Mitamura; Keisei Kawa; Shunichi Kato; Tokiko Nagamura; Minoko Takanashi; Yoshihisa Kodera
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

10.  Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation.

Authors:  T Yasuda; T Ueno; K Fukumura; A Yamato; M Ando; H Yamaguchi; M Soda; M Kawazu; E Sai; Y Yamashita; M Murata; H Kiyoi; T Naoe; H Mano
Journal:  Leukemia       Date:  2013-09-26       Impact factor: 12.883
View more
  13 in total

1.  Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias.

Authors:  Christopher J Gibson; James A Kennedy; Sarah Nikiforow; Frank C Kuo; Edwin P Alyea; Vincent Ho; Jerome Ritz; Robert Soiffer; Joseph H Antin; R Coleman Lindsley
Journal:  Blood       Date:  2017-04-26       Impact factor: 22.113

2.  Post-Transplantation Cyclophosphamide after Bone Marrow Transplantation Is Not Associated with an Increased Risk of Donor-Derived Malignancy.

Authors:  Robbie G Majzner; Huzefa Mogri; Ravi Varadhan; Patrick Brown; Kenneth R Cooke; Javier Bolaños-Meade; Lode Swinnen; Jennifer Kanakry; Leo Luznik; Richard J Jones; Ephraim Fuchs; Rich Ambinder; Yvette Kasamon; Heather J Symons
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-03       Impact factor: 5.742

3.  Stem cell donors should not be screened for clonal hematopoiesis.

Authors:  Christopher J Gibson; R Coleman Lindsley
Journal:  Blood Adv       Date:  2020-02-25

Review 4.  Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome.

Authors:  Lacey Williams; Kimberley Doucette; Judith E Karp; Catherine Lai
Journal:  Bone Marrow Transplant       Date:  2021-03-08       Impact factor: 5.483

5.  Tissue-based chimerism analysis enhances detection of donor-derived neoplasia in allogeneic stem cell transplant patients.

Authors:  E G Baraban; S Hu; P Hui; N Podoltsev; D Cooper; M L Xu
Journal:  Bone Marrow Transplant       Date:  2016-12-19       Impact factor: 5.483

6.  Pseudo-autologous stem cell transplantation for donor-derived mantle cell lymphoma 12 years after allogeneic transplantation.

Authors:  Masaharu Tamaki; Hidenori Wada; Ayumi Gomyo; Jin Hayakawa; Yu Akahoshi; Naonori Harada; Machiko Kusuda; Yuko Ishihara; Koji Kawamura; Aki Tanihara; Miki Sato; Kiriko Terasako-Saito; Kazuaki Kameda; Misato Kikuchi; Shun-Ichi Kimura; Hideki Nakasone; Shinichi Kako; Yoshinobu Kanda
Journal:  Int J Hematol       Date:  2017-07-06       Impact factor: 2.490

7.  Jumping translocations of 1q in donor cell-derived myelodysplastic syndrome after cord blood transplantation: Case report and review of the literature.

Authors:  Toshinori Kondo; Taizo Tasaka; Risa Shimizu; Kiyohito Hayashi; Seiko Yamada; Hirofumi Fukuda; Tadashi Hirose; Asako Takeuchi; Fuminori Sano; Hirotoshi Tokunaga; Yoshiko Matsuhashi; Hideho Wada
Journal:  Mol Clin Oncol       Date:  2020-02-06

8.  Engraftment of rare, pathogenic donor hematopoietic mutations in unrelated hematopoietic stem cell transplantation.

Authors:  Wing Hing Wong; Sima Bhatt; Kathryn Trinkaus; Iskra Pusic; Kevin Elliott; Nitin Mahajan; Fei Wan; Galen E Switzer; Dennis L Confer; John DiPersio; Michael A Pulsipher; Nirali N Shah; Jennifer Sees; Amelia Bystry; Jamie R Blundell; Bronwen E Shaw; Todd E Druley
Journal:  Sci Transl Med       Date:  2020-01-15       Impact factor: 17.956

9.  Acute Megakaryoblastic Leukemia Developing as Donor Cell Leukemia after Umbilical Cord Blood Transplantation.

Authors:  Yoshitaka Adachi; Yohei Yamaguchi; Ken Sagou; Yusuke Yamaga; Nobuaki Fukushima; Kazutaka Ozeki; Akio Kohno
Journal:  Intern Med       Date:  2017-11-20       Impact factor: 1.271

Review 10.  Cancer cell transmission via the placenta.

Authors:  Mel Greaves; William Hughes
Journal:  Evol Med Public Health       Date:  2018-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.